Search

everythinglearnresearchcommunity

for

Search:↓

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Flaxseed lignans may reduce breast cancer risk in women.

Dermatologists should focus on restoring skin health and well-being in cancer survivors.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Cnicus Benedictus leaf extract can kill cervical cancer cells without harming normal cells.

Patients with hematologic cancer had mild anxiety, low surgical knowledge, and the pandemic increased their anxiety.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Physical activity, height, and smoking affect prostate cancer risk.

Enhancing immune response can improve cancer treatment effectiveness.

Anti-angiogenic drugs do not worsen COVID-19 severity in lung cancer patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Women with female pattern hair loss tend to have lower self-esteem and body image concerns, but higher self-esteem is linked to more self-compassion.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.